Mesoblast (MESO) Reports Q1 Loss of $0.04/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mesoblast Provides Strategic Update and Reports on First Quarter Financial Results
December 16, 2015 4:57 PM ESTMaterially Strengthened Cash Reserves
First Royalties From TEMCELL Product Sales Expected In Q1 2016
Resources Prioritized On Tier 1 Product Candidates
Cash Managed To Extend Runway And Achieve Tier 1 Value Inflexion Points
Major Focus Is FDA Filing For Our First US Product Approval In Acute Graft Versus Host Disease
MELBOURNE, Australia; and NEW YORK, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:... More
Mesoblast to Host First Quarter Financial Results Conference Call and Webcast on 16 December 2015
December 15, 2015 7:52 PM ESTMELBOURNE, Australia and NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB) (Nasdaq: MESO) today announced it will report financial results for the quarter ended 30 September 2015 after the close of the Nasdaq market on Wednesday 16 December. Mesoblast management will host a conference call to review results and provide a corporate update beginning at 5:00 pm Eastern Time on... More
